These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 38075897)

  • 21. Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing
    Wieërs G; Verbelen V; Van Den Driessche M; Melnik E; Vanheule G; Marot JC; Cani PD
    Front Public Health; 2020; 8():578089. PubMed ID: 33763399
    [No Abstract]   [Full Text] [Related]  

  • 22. Gut Microbiota Modulation and Prevention of Dysbiosis as an Alternative Approach to Antimicrobial Resistance: A Narrative Review.
    Matzaras R; Nikopoulou A; Protonotariou E; Christaki E
    Yale J Biol Med; 2022 Dec; 95(4):479-494. PubMed ID: 36568836
    [No Abstract]   [Full Text] [Related]  

  • 23. A Simple In Vitro Test to Select Stools for Fecal Microbiota Transplantation to Limit Intestinal Carriage of Extensively Drug-Resistant Bacteria.
    Salandre A; Delannoy J; Goudiaby MTB; Barbut F; Thomas M; Waligora-Dupriet AJ; Kapel N
    Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration of carriage of multidrug-resistant bacteria in dogs and cats in veterinary care and co-carriage with their owners.
    Dazio V; Nigg A; Schmidt JS; Brilhante M; Campos-Madueno EI; Mauri N; Kuster SP; Brawand SG; Willi B; Endimiani A; Perreten V; Schuller S
    One Health; 2021 Dec; 13():100322. PubMed ID: 34522760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug-Resistant and Extended-Spectrum β-Lactamase (ESBL) - Producing
    Zemtsa RJ; Noubom M; Founou LL; Dimani BD; Koudoum PL; Mbossi AD; Kouanfack C; Founou RC
    Pathogens; 2022 Apr; 11(5):. PubMed ID: 35631025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Phage Therapy on Multidrug-Resistant
    Javaudin F; Bémer P; Batard E; Montassier E
    Microorganisms; 2021 Dec; 9(12):. PubMed ID: 34946183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
    Tacconelli E; Mazzaferri F; de Smet AM; Bragantini D; Eggimann P; Huttner BD; Kuijper EJ; Lucet JC; Mutters NT; Sanguinetti M; Schwaber MJ; Souli M; Torre-Cisneros J; Price JR; Rodríguez-Baño J
    Clin Microbiol Infect; 2019 Jul; 25(7):807-817. PubMed ID: 30708122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Use of Microbiome Restoration Therapeutics to Eliminate Intestinal Colonization With Multidrug-Resistant Organisms.
    Gopalsamy SN; Woodworth MH; Wang T; Carpentieri CT; Mehta N; Friedman-Moraco RJ; Mehta AK; Larsen CP; Kraft CS
    Am J Med Sci; 2018 Nov; 356(5):433-440. PubMed ID: 30384952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colonization with Multidrug-Resistant Bacteria - On the Efficiency of Local Decolonization Procedures.
    Münch J; Hagen RM; Müller M; Kellert V; Wiemer DF; Hinz R; Schwarz NG; Frickmann H
    Eur J Microbiol Immunol (Bp); 2017 Jun; 7(2):99-111. PubMed ID: 28690877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Strategies for the Management of Vancomycin-Resistant Enterococcal Infections.
    Contreras GA; Munita JM; Arias CA
    Curr Infect Dis Rep; 2019 May; 21(7):22. PubMed ID: 31119397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fifty shades of graft: How to improve the efficacy of faecal microbiota transplantation for decolonization of antibiotic-resistant bacteria.
    Davido B; Batista R; Dinh A; de Truchis P; Terveer EM; Roberts B; Kuijper EJ; Caballero S
    Int J Antimicrob Agents; 2019 May; 53(5):553-556. PubMed ID: 30880228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study.
    Bilinski J; Grzesiowski P; Sorensen N; Madry K; Muszynski J; Robak K; Wroblewska M; Dzieciatkowski T; Dulny G; Dwilewicz-Trojaczek J; Wiktor-Jedrzejczak W; Basak GW
    Clin Infect Dis; 2017 Aug; 65(3):364-370. PubMed ID: 28369341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal decolonization of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature.
    Rieg S; Küpper MF; de With K; Serr A; Bohnert JA; Kern WV
    BMC Infect Dis; 2015 Oct; 15():475. PubMed ID: 26511929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria.
    Battipaglia G; Malard F; Rubio MT; Ruggeri A; Mamez AC; Brissot E; Giannotti F; Dulery R; Joly AC; Baylatry MT; Kossmann MJ; Tankovic J; Beaugerie L; Sokol H; Mohty M
    Haematologica; 2019 Aug; 104(8):1682-1688. PubMed ID: 30733264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.
    Cieplak T; Soffer N; Sulakvelidze A; Nielsen DS
    Gut Microbes; 2018; 9(5):391-399. PubMed ID: 29517960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal and Systemic Immune Responses upon Multi-drug Resistant
    von Klitzing E; Ekmekciu I; Bereswill S; Heimesaat MM
    Front Microbiol; 2017; 8():2590. PubMed ID: 29312263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Potential of Probiotics to Eradicate Gut Carriage of Pathogenic or Antimicrobial-Resistant
    Hung YP; Lee CC; Lee JC; Tsai PJ; Hsueh PR; Ko WC
    Antibiotics (Basel); 2021 Sep; 10(9):. PubMed ID: 34572668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug-resistant
    Antony S; Ravichandran K; Kanungo R
    Indian J Med Microbiol; 2018; 36(4):488-493. PubMed ID: 30880694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caretaker knowledge, attitudes, and practices (KAP) and carriage of extended-spectrum beta-lactamase-producing E. coli (ESBL-EC) in children in Quito, Ecuador.
    Marusinec R; Kurowski KM; Amato HK; Saraiva-Garcia C; Loayza F; Salinas L; Trueba G; Graham JP
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):2. PubMed ID: 33407927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.